Divalproex Sodium Extended-Release Tablets

DRUG4 trials

Sponsors

Abbott, Northwestern University, Virginia Commonwealth University

Conditions

Bipolar DisorderElderlyEpilepsySchizoaffective DisorderSchizophreniaSeizures

Phase 2

Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

CompletedNCT00073164

AbbottSchizophrenia

Start: 2003-07-31Target: 400Updated: 2006-08-04

Phase 3

An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents

CompletedNCT00067262

AbbottBipolar Disorder

Start: 2003-03-31Target: 150Updated: 2006-08-04

Phase 4

Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?

CompletedNCT00306475

Northwestern UniversitySchizoaffective Disorder, Schizophrenia

Start: 2006-03-31End: 2008-04-30Updated: 2025-06-27

Unknown Phase

Tolerability and Efficacy of Depakote-extended Release in the Elderly

CompletedNCT00318929

Virginia Commonwealth UniversityElderly, Epilepsy, Seizures

Start: 2006-04-30End: 2008-01-31Updated: 2018-02-05